| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Evans Department of Medicine and Departments of 3 Surgery and 5 Biochemistry, Boston University Medical Center, Boston, Massachusetts 02118; 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, the Mayo Clinic, Rochester, Minnesota 55905; and 4 AdipoGenix, Boston, Massachusetts 02118
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Fat distribution varies among
individuals with similar body fat content. Innate differences in
adipose cell characteristics may contribute because lipid accumulation
and lipogenic enzyme activities vary among preadipocytes
cultured from different fat depots. We determined expression of the
adipogenic transcription factors peroxisome proliferator activated
receptor-
(PPAR-) and CCAAT/enhancer binding protein-
(C/EBP-) and their targets in abdominal subcutaneous, mesenteric,
and omental preadipocytes cultured in parallel from obese subjects.
Subcutaneous preadipocytes, which had the highest lipid accumulation,
glycerol-3-phosphate dehydrogenase (G3PD) activity, and adipocyte fatty
acid binding protein (aP2) abundance, had highest PPAR- and
C/EBP- expression. Levels were intermediate in mesenteric
and lowest in omental preadipocytes. Overexpression of C/EBP- in
transfected omental preadipocytes enhanced differentiation. The
proportion of differentiated cells in colonies derived from single
subcutaneous preadipocytes was higher than in mesenteric or omental
clones. Only cells that acquired lipid inclusions exhibited C/EBP-
upregulation, irrespective of depot origin. Thus regional variation in
adipogenesis depends on differences at the level of transcription
factor expression and is a trait conferred on daughter cells.
adipocyte fatty acid binding protein; fatty acid binding protein; peroxisome proliferator activated receptor-; CCAAT/enhancer binding
protein-
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
REGIONAL DISTRIBUTION of fat tissue varies considerably, even among individuals with the same total body fat content. For several decades, it has been appreciated that fat tissue is regionally heterogeneous with respect to metabolic function (2, 29, 30). Fat cells isolated from different depots of rats and humans differ in size, responses to insulin and lipolytic agents, lipoprotein lipase release, lipid synthetic capacity, fatty acid incorporation, and other characteristics (2, 6, 11, 14, 18, 23, 36, 37, 47, 53, 56, 58). These observations lead to the following question: Is interdepot variation solely a result of influences extrinsic to adipose cells (including their hormonal and paracrine microenvironment, local nutrient availability, innervation, and anatomic constraints), or do intrinsic differences in the innate characteristics of adipose cells also contribute? The latter may be the case because regional variation in capacity for differentiation of preadipocytes cultured in identical conditions originating from various depots from the same individuals has been observed (1, 9, 10, 19, 32, 33, 61). A problem with the studies of effects of fat depot origin on human preadipocyte differentiation is that interdepot differences in extent of contamination of primary cultures with nonadipose cell types, such as mesothelial cells and fibroblasts, are a potential cause of apparent differences in adipogenesis. Additionally, it has not been clear if interdepot differences in human preadipocyte capacity for differentiation depend on variation at the level of adipogenic transcription factor expression or solely on later events during the differentiation process.
To explore the cellular and molecular basis for regional differences in
human preadipocyte function, we determined effects of fat depot origin
on the key adipogenic transcription factors, peroxisome proliferator
activated receptor- (PPAR-) and CCAAT/enhancer binding
protein- (C/EBP-), and downstream targets, glycerol-3-phosphate dehydrogenase (G3PD) and adipocyte fatty acid binding protein (aP2), in
abdominal subcutaneous, mesenteric, and omental preadipocytes. Abdominal subcutaneous and omental preadipocytes were studied for the
following reasons. Differences in lipid accumulation, lipogenic enzyme
activities, and function of preadipocytes and fat cells isolated from
these depots have been found (1, 6, 11, 23, 47, 53).
Increased visceral relative to subcutaneous fat is associated with
increased risk of atherosclerosis, diabetes, hypertension, and
dyslipidemia (5, 8, 15, 16, 25, 35-37, 40, 44, 51).
Little is known about the characteristics of preadipocytes from
the other major visceral fat depot, the mesenteric depot, which were
therefore also studied.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Human subjects. Fat tissue was resected during gastric bypass surgery for management of obesity from 16 subjects who had given informed consent. The protocol was approved by the Boston University Medical Center Institutional Review Board for Human Research. All subjects had fasted at least 10 h. Four of the subjects were men and 12 were women. Subjects were 42 ± 2 yr of age (mean ± SE; range 29-61). The subjects' mean body mass index was 54 ± 2 kg/m2. Subjects with malignancies were excluded. No subjects were taking thiazolidinediones or steroids. None had fasting plasma glucose levels over 120 mg%. Two to 10 g of abdominal subcutaneous (external to the fascia superficialis), mesenteric, and greater omental fat were obtained from each subject.
Preadipocyte culture. Fat tissue was minced and then digested in Hanks' balanced salt solution containing 1 mg/ml collagenase and 7.5% fetal bovine serum (FBS) in a 37°C shaking water bath until fragments were no longer visible and the digest had a milky appearance. Digests were filtered and centrifuged at 800 g for 10 min. The digests were treated with an erythrocyte lysis buffer to improve subsequent differentiation (20, 60). The cells were then plated by using a low-serum plating medium (1:1 DMEM:Ham's F12 that contained 0.5% bovine serum and antibiotics) at a density of 4 × 104 cells/cm2. Macrophages were rare (<5 per 106 cells as assessed by phase-contrast microscopy) in the replated cultures, irrespective of fat depot origin. Plating medium was changed every 2 days until confluence.
Preadipocyte cloning. Preadipocytes were isolated as described above and were plated at a density of 50 cells/96-well plate in plating medium. At this density, the probability of any one well's being seeded by more than one cell is <2% (32, 61). After 2 wk, colonies were evident and by 3 wk, some were near confluence. Cloning efficiency ranged from 10 to 30%. From 3 wk, the clones were exposed to the differentiation-inducing medium described below. The percentage of clones that contained at least one differentiated cell was determined 15, 30, 45, and 60 days after addition of differentiation-inducing medium by observers who did not know the fat depot origin of the cultures. Also, the percentage of cells within each of the colonies that had differentiated was determined after 30 days. A differentiated cell was considered to be one that contained doubly refractile inclusions visible by low-power phase-contrast microscopy, as previously described in cloned rat preadipocyte studies (32, 61). The lipid nature of these inclusions was confirmed by staining with oil red O. Human lung fibroblasts cultured under identical conditions never developed such lipid inclusions after up to 60 days of treatment with differentiation-inducing medium.
Preadipocyte differentiation. From confluence, first to fourth passage cells were either held in an undifferentiated state by using plating medium without serum, or were differentiated. For differentiation, a previously published method (21) was used with modifications that included the following. Mass cultures were treated for 7-10 days (4 h to 14 days in differentiation time course experiments) and clones for up to 60 days (as indicated in RESULTS and figure legends) with plating medium (without serum) enriched with 100 nM dexamethasone, 500 nM human insulin, 200 pM triiodothyronine, 0.5 µM rosiglitazone, antibiotics, and 540 µM IBMX (removed after 2 days). In preliminary studies, higher rosiglitazone and insulin concentrations did not further enhance differentiation of subcutaneous, mesenteric, or omental preadipocytes. Medium was changed every 2 days in mass cultures and weekly in clones.
DNA transfection.
Omental preadipocytes were cotransfected with pMT2rC/EBP- and
pMSV-
gal (Invitrogen) at a by molar ratio of 5:1 (transcription factor:reporter construct) by using the calcium phosphate precipitation method (62) without glycerol shock treatment to ensure
that transfected cells detected by staining for -galactosidase would also be expressing C/EBP-. Approximately 15% of transfected cells were positive for -galactosidase. Increased C/EBP- expression in
transfected cells was verified by Western immunoanalysis. Mock-control cells were transfected with a plasmid, PVG 9607(GAPDH)
(41), that expresses glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and that had no effect on lipid
accumulation compared with untransfected cells, and pMSV-gal, also
at a 5:1 molar ratio. After 48 h of culture in differentiation
medium, cultures were fixed in 3% formaldehyde and stained with the
chromatographic -galactosidase substrate, x-gal, to identify
transfected cells (57). Observers unaware of the origin of
the cells assessed extent of differentiation by examining transfected
cells for the presence of doubly refractile lipid inclusions by using
low-power phase-contrast microscopy (32, 61). The
proportion of transfected cells containing such inclusions was compared
with that of parallel mock-control cultures.
Glycerol-3-phosphate dehydrogenase. Glycerol-3-phosphate dehydrogenase (G3PD) was measured in supernatants of cell homogenates by following NADH disappearance spectrophotometrically (39), as described previously (34). G3PD activity was below the detection limit of our assay in undifferentiated cells.
Western immunoblot analyses.
Cultures were washed with PBS and scraped into RIPA buffer
(64). SDS-PAGE was performed (43). The
protein was transferred to Immobilon polyvinylidene difluoride
membranes for probing, and the gels were stained to visualize banding
and confirm protein integrity. Blotting paper was blocked for 1 h
at room temperature in Tris-buffered saline containing 5% milk, 0.5%
BSA, and 0.1% Tween 20. Incubation with anti-aP2 primary antibody
(kindly provided by D. A. Bernlohr) was for 1 h at 24°C and
with anti-PPAR- antibody [cat. no. sc-7273 (E-8), Santa Cruz
Biotechnology, Santa Cruz, CA] was for 4 h (45).
Blots were incubated for 30 min at room temperature with secondary
antibody conjugated to horseradish peroxidase. Visualization of
secondary antibody binding was performed by chemiluminescence. Five
micrograms of protein were loaded in each lane for measuring aP2 and 20 µg for measuring PPAR-. In preliminary studies, linearity was
confirmed over the range of aP2 and PPAR- levels encountered in
preadipocytes when these amounts of protein were loaded. Total protein
contents (pg/cell) were 305 ± 32 and 310 ± 38 in
undifferentiated and differentiated preadipocytes, respectively.
Protein was quantified by densitometry.
Confocal immunofluorescence studies.
Abdominal subcutaneous, mesenteric, and omental preadipocyte clones
from three subjects were exposed to differentiation medium for 15, 55, and 55 days, respectively. The clones were washed twice with PBS, fixed
in 1% paraformaldehyde for 20 min, and washed again with water. The
clones were incubated for 10 min in DAKO serum-free protein blocking
buffer (cat. no. X0909, DAKO, Carpinteria, CA) and 0.1% saponin (cat.
no. S-7900, Sigma Chemicals, St. Louis, MO). Next, the clones were
incubated for 1 h in 50 µl of a 1:37.5 dilution of rabbit
polyclonal anti-C/EBP- antibody (cat. no. sc-61, Santa Cruz Biotech)
at room temperature, washed in PBS, and fluorescently labeled in a
1:200 dilution of a chicken anti-rabbit antibody conjugated with Alexa
Fluor 488 fluorochrome (A-21441, Molecular Probes, Eugene, OR).
After a final wash with PBS, images of the labeled cells were
immediately collected on an LSM510 confocal system (Zeiss, Oberkochen,
Germany) equipped with an Axiovert 100M inverted microscope and an
LD-Achroplan 40×/0.6 NA objective lens. Excitation was from the 488-nm
line of an argon/krypton laser. Emission was detected above 505 nm.
RNA analysis.
For RNA analyses, RNA was isolated from preadipocytes by using
the guanidinium thiocyanate-phenol method (7). RNA
integrity was verified by using 1% formaldehyde-containing denaturing
agarose gels. mRNA was measured by relative quantitative RT-PCR in
which target genes were coamplified with internal control sequences [18S rRNA or hypoxanthine phosphoribosyl transferase (HPRT)]
(49). Analysis of mRNA expression was carried out during
the exponential phase of the amplification, which was assessed in
preliminary experiments for each set of primers. Amplified product
reproducibility was confirmed by two PCR rounds. The ratios of
intensity of target to internal control bands were used to indicate the
relative abundance of message in the samples. This allows quantitative
data to be obtained because 18S rRNA and HPRT abundance are not
affected by depot origin or differentiation of preadipocytes. 18S rRNA amplification was titrated to match that of PPAR-1 and -2 by adding competitive primers (Ambion, Austin, TX) that modulate extension
of the 18S cDNA. HPRT mRNA abundance was close to that of C/EBP-.
The quantitative nature of this approach was confirmed by measuring the
transcription factor mRNAs in serially diluted samples. RNA
preparations were checked for DNA contamination by amplifying control
aliquots that had not been reverse transcribed. The following primers
were used: for PPAR-1, sense CTCGAGGACACCGGAGAGG and antisense
GCATTATGAGACATCCCCAC (based on sequence accession no. NM002957); for
PPAR-2, sense GCGATTCCTTCACTGATAC and antisense GCATTATGAGACATCCCCAC
(3); for C/EBP-, sense GACACGCTGCGGGGCATCT and
antisense CTGCTCCCCTTCCTTCTCTCA (65); and for HPRT, sense CTTGCTCGAGATGTCATGAAG and antisense GTTTGCATTGTTTTACCAGTG (based on
sequence accession no. J00423).
Statistical analysis. Results are means ± SE, and significance determination was by paired t-tests or ANOVA with post hoc comparisons by Duncan's multiple range test (24, 28). P < 0.05 was considered significant. In transfection experiments, comparisons of numbers of transfected cells were made by logistic regression analysis, with P values determined from log likelihood ratios (38).
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Preadipocyte differentiation depends on fat depot origin.
Extent of lipid accumulation was determined in abdominal subcutaneous,
omental, and mesenteric preadipocytes that had been isolated from the
same subjects. After the preadipocytes had been treated with
differentiation-inducing medium for 10 days following confluence,
morphologically apparent lipid accumulation was greatest in
differentiating abdominal subcutaneous preadipocytes, less extensive in
mesenteric cells, and least extensive in omental cells (Fig.
1). G3PD activity exhibited a similar
pattern. After 10 days of treatment with differentiation medium,
primary abdominal subcutaneous preadipocyte G3PD activity was 720 ± 184, mesenteric was 99 ± 47, and omental was 14 ± 4 nmol · s
1 · 106
cells1 (effect of depot origin: P < 0.001; n = 6; ANOVA; subcutaneous > mesenteric or
omental, P < 0.05; Duncan's multiple range test).
|
aP2 expression increases earlier and to a greater extent in
subcutaneous than visceral differentiating preadipocytes.
Interdepot variation in aP2 protein abundance exhibited a pattern
similar to that of lipid accumulation and G3PD activity (Fig.
2). Fourth passage abdominal
subcutaneous, mesenteric, and omental preadipocytes were treated for 10 days either with differentiation-inducing medium or a control, basal
medium that does not promote differentiation. Abundance of aP2 was
higher in abdominal subcutaneous than mesenteric cells
(P < 0.01; Duncan's multiple range test;
n = 6) and lower in omental than mesenteric
preadipocytes (P < 0.01). Undifferentiated cells
expressed little aP2 (1.7 ± 1.0, 2.4 ± 1.0, and 2.3 ± 1.3% in abdominal subcutaneous, mesenteric, and omental preadipocytes, respectively; effect of differentiation, P < 0.00001;
effect of fat depot origin, P = nonsignificant; ANOVA).
|
|
Adipogenic transcription factor expression is higher in
differentiating subcutaneous than visceral preadipocytes.
Because adipogenesis in general, and aP2 and G3PD expression in
particular, depend on PPAR- expression, we measured the time course
of PPAR- protein expression in abdominal subcutaneous and omental
preadipocytes (Fig. 4). Abdominal
subcutaneous preadipocytes expressed more PPAR- protein,
particularly the more adipose-specific PPAR-2 isoform, than omental
preadipocytes throughout the course of differentiation.
|
2
expression is pretranslational, PPAR-1 and -2 mRNA levels were
assayed in abdominal subcutaneous, mesenteric, and omental third
passage preadipocytes that had been treated with
differentiation-inducing medium for 7 days (Fig.
5). Both PPAR-1 and -2 mRNA levels
were higher in abdominal subcutaneous than in visceral preadipocytes cultured from the same subjects (abdominal subcutaneous > mesenteric or omental, P < 0.01; n = 5; Duncan's multiple range test). Thus variations in PPAR- and aP2
expression, G3PD activity, and lipid accumulation among depots are
similar.
|
expression are
enhanced in rodent preadipocyte cell lines by C/EBP- (22, 52,
63). Interdepot variation in preadipocyte C/EBP- mRNA abundance in differentiating human preadipocytes mirrored that of
PPAR-2. C/EBP- expression was higher in abdominal subcutaneous than mesenteric preadipocytes treated with differentiation-inducing medium for 7 days (Fig. 6;
P < 0.01; n = 5; Duncan's multiple range test). C/EBP- was more abundant in mesenteric than omental preadipocytes (P < 0.01; n = 5;
Duncan's multiple range test). Furthermore, C/EBP- overexpression
enhanced lipid accumulation in omental preadipocytes (Fig.
7). C/EBP- and -gal expression vectors were cotransfected at a 5:1 molar ratio so that only cells transfected with C/EBP- would be detected by -gal staining
(26). Control cells were transfected with a GAPDH
expression vector, also with the -gal expression vector at a 5:1
molar ratio. After 7 days of treatment with differentiation-inducing
medium, the proportions of -gal-expressing cells that contained
doubly refractile lipid inclusions visible by low-power phase-contrast
microscopy were determined in C/EBP-- and control-transfected
cultures by observers who were unaware of the treatments performed on
the cultures. Over threefold more omental preadipocytes transfected with the C/EBP- expression vector accumulated lipid than did control
cells (odds ratio 3:1; 95% confidence interval 2.1-4.5; P < 0.0001; n = 3 subjects, 100 C/EBP-- and 100 mock-transfected cells/subject). Thus adipogenesis
in omental preadipocytes is augmented by C/EBP- overexpression, and
genes responsible for lipid accumulation are capable of responding to
overexpressed levels of C/EBP- in omental cells.
|
|
Cloned preadipocytes exhibit regional differences in adipogenesis.
Stromal vascular digests can contain mesothelial cells, macrophages,
and other cell types in addition to preadipocytes. These nonadipose
cell types could contribute to apparent regional variation in
adipogenesis in primary cultures. To test this possibility, colonies
arising from single abdominal subcutaneous, mesenteric, and omental
cells cloned by plate dilution from three different patients were
exposed to differentiation-inducing medium for 60 days
(n = 20-376 clones per fat depot per patient).
Regional differences in adipogenesis were evident in these clones (Fig.
8). The percentage of colonies that
contained at least one differentiated cell (doubly refractile
inclusions visible by low-power phase-contrast microscopy) was
determined after 15, 30, 45, and 60 days. After 60 days, differentiated cells were found in every colony, confirming the purity of the preadipocyte cultures isolated by using our methods (Fig.
9). No such differentiated cells with
doubly refractile inclusions were found in human lung fibroblasts
cultured under identical conditions. Thus admixture with other cell
types does not explain regional differences in adipogenesis.
|
|
|
than
less differentiated cells, irrespective of fat depot origin (Fig.
11). Sixty abdominal subcutaneous, 61 mesenteric, and 37 omental clones from three subjects were treated with
C/EBP- antibody and examined by confocal microscopy. Abdominal
subcutaneous clones, which exhibited the most extensive
differentiation, were studied after 15 days so that fields containing
cells with little lipid accumulation, as well as fields with extensive
lipid accumulation, could be examined. By 55 days after induction of
differentiation, it was difficult to find subcutaneous clones with
fields of cells that did not contain lipid. Visceral preadipocyte
clones, in which differentiation occurred later than in subcutaneous
clones, were examined after 55 days so fields containing cells with
extensive, as well as limited, lipid accumulation could also be
examined. We found that those cells with the highest nuclear C/EBP-
expression also exhibited the most differentiated morphology,
suggesting that the mechanism responsible for regional differences in
adipogenesis operates upstream of C/EBP-.
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Fat depot origin affects the capacity of human preadipocytes
to differentiate, potentially contributing to regional differences in
adipose tissue growth and function. Abdominal subcutaneous cells had
the highest adipogenic capacity, as indicated by lipid accumulation,
G3PD activity, and aP2, PPAR-, and C/EBP- expression. Mesenteric
cells, which have rarely been studied in the past, had an intermediate
capacity for adipogenesis, and omental cells had the lowest.
Adipogenesis took longer in omental than in subcutaneous cells. In
another study, lipid accumulation and G3PD activity were higher in
differentiating human abdominal than in femoral subcutaneous
preadipocytes (19). Thiazolidinediones (PPAR- activating ligands) caused more extensive differentiation of human subcutaneous than omental cells (1). Together, these
findings support the hypothesis that fat depot origin affects capacity of preadipocytes to differentiate in humans.
Other differences in the characteristics of human preadipocytes from
various depots have been described. Greater susceptibility of human
omental than abdominal subcutaneous preadipocytes to apoptosis
induced by serum deprivation and tumor necrosis factor- has been
found (50). We found more extensive transfer of fatty acids into differentiated human omental than abdominal subcutaneous preadipocytes from the same subjects, even after matching cells for
lipid content, consistent with the greater fatty acid flux in visceral
than in subcutaneous fat (6). In these other studies, regional differences in preadipocyte characteristics were
evident in cells cultured under identical conditions for up to four
subcultures, and in the current study, in colonies arising from single
cells for over 60 days. Thus preadipocytes from different regions
appear to be inherently distinct.
Rat studies also support the contention that fat cells from different regions are inherently distinct. Preadipocytes cultured from perirenal depots were shown to be capable of more extensive replication and differentiation in vitro and in vivo than preadipocytes from epididymal depots (9, 10, 32, 33, 46, 61). Despite exposure to similar hormonal manipulations in vivo such as estrogen administration, hypophysectomy, or castration, preadipocytes cultured from various depots of rats retained distinct cell dynamic and biochemical responses (31, 42). These depot-dependent differences in the innate characteristics of adipose cells could contribute to anatomic variation in function. Indeed, interdepot variation in cultured rat preadipocyte differentiation-dependent gene expression was reflected in differences among depots in expression of the same genes in fat cells (33). Thus rat preadipocyte studies are in accord with the hypothesis that interdepot variation in fat cell function reflects differences in the innate characteristics of adipose cells themselves, in addition to any effects of variation in nutrient supply, innervation, and other extrinsic factors.
We studied effects of fat depot origin on differentiation of preadipocytes from obese subjects. Because preadipocyte capacities for replication and mitogenic protein release are increased in some massively obese subjects compared with lean controls (54, 59), patterns of regional differences in adipogenesis could also be influenced by obesity. Another question arising from this work is whether the pattern of regional variation in adipogenesis of preadipocytes from subjects with peripheral obesity is distinct from that in subjects with visceral obesity. Thus it will be interesting to determine how fat depot origin affects preadipocyte differentiation in lean compared with obese subjects and in subjects with central compared with peripheral obesity.
Lipid accumulation, aP2 expression, and G3PD activity were highest in
abdominal subcutaneous preadipocytes, intermediate in mesenteric cells,
and lowest in omental cells. Because this pattern was also observed
with respect to PPAR- and C/EBP- expression, these associations
may be causal because PPAR- and C/EBP- are key adipogenic
transcription factors. When either of these factors is absent in
transgenic animal models, adipogenesis is blocked. In rodent cell
lines, expression of PPAR- is linked to that of C/EBP-, and
effects of C/EBP- and PPAR- on adipogenesis are complementary
(12). The aP2 and G3PD promoters respond to PPAR- and
C/EBP- (4, 22, 52, 55). The magnitudes of the regional differences in C/EBP- and PPAR- expression we found are
consistent with the regional differences in aP2 and G3PD
abundance. Furthermore, ectopic expression of C/EBP- in
omental preadipocytes enhanced their capacity to accumulate lipid,
suggesting that genes downstream of C/EBP- in omental preadipocytes
are capable of responding to overexpressed levels of this adipogenic
regulator. These findings suggest that there are mechanisms
contributing to regional differences in adipogenesis that operate
upstream of the induction of C/EBP- expression during differentiation.
Others have reported that, even though thiazolidinediones caused
more extensive differentiation of subcutaneous than omental cells,
PPAR- expression was the same in human subcutaneous and omental
preadipocytes (1). However, the methods used in these studies were not intended to result in extensive morphologically evident differentiation, unlike the methods we employed, perhaps obscuring potential interdepot differences. Possibly, therefore, the
low responsiveness of omental preadipocytes to thiazolidinediones is partly a result of reduced PPAR- expression. Regional
differences in PPAR- abundance and thiazolidinedione
responsiveness could be a mechanism contributing to the antidiabetic
effects of thiazolidinediones. Excess visceral relative to subcutaneous
fat has been associated with glucose intolerance (58).
Thiazolidinediones have been reported to promote greater enlargement of
subcutaneous than visceral fat (27, 48). This increase in
the ratio of subcutaneous to visceral fat may be related to more
extensive differentiation of subcutaneous than visceral preadipocytes,
potentially improving glucose tolerance.
To exclude possible effects of admixture of other cell types in primary
preadipocyte cultures from different regions and to test effects of fat
depot origin on adipogenesis definitively, we cloned preadipocytes from
different regions. Differences in adipogenesis were evident in colonies
derived from single preadipocytes from different fat depots.
Differentiated cells appeared later in visceral than subcutaneous
clones. Together with our finding that differentiation-dependent
increases in aP2 expression are delayed in omental compared with
subcutaneous preadipocytes in mass cultures, this indicates that fat
depot origin affects the duration of exposure to
differentiation-inducing conditions required for adipogenesis to occur.
Although adipogenesis is delayed in omental compared with abdominal
subcutaneous preadipocytes, it does eventually proceed. This is
consistent with the finding that PPAR- mRNA abundance is similar in
abdominal subcutaneous and omental whole fat tissue samples
(1).
Perspectives
The proportion of differentiated cells was lowest in omental, intermediate in mesenteric, and highest in subcutaneous colonies, even though they had originated from single cells. Not every cell within clones differentiated at the same time. Therefore, a stochastic differentiation switch appears to exist. The propensities of preadipocytes from different fat depots in primary cultures to switch on the differentiation program were reflected in colonies derived from single cells. The cloning studies indicate that the likelihood of this switching mechanism to trigger differentiation is a trait transferred to daughter cells, as has been suggested in studies in aneuploid rodent preadipocyte cell lines (17). The switch may operate upstream of the induction of C/EBP- expression that occurs during
adipogenesis, because C/EBP- overexpression enhanced adipogenesis in
visceral preadipocytes, and increased C/EBP- expression was only
observed in individual preadipocytes that also exhibited increased
lipid accumulation. If the event responsible for regional differences
in adipogenesis only operated downstream of C/EBP- induction, a high
proportion of cells expressing C/EBP-, but not accumulating lipid,
should have been found in omental or mesenteric compared with
subcutaneous clones. This stochastic switch could require different
thresholds or durations of exposure to differentiation inducers before
triggering differentiation. Alternatively, the differentiation process,
once triggered, could proceed at different rates depending on fat depot
origin. Regional variation in this mechanism appears to be a cause
of delayed and less extensive differentiation and responsiveness to
thiazolidinediones in visceral compared with subcutaneous preadipocytes.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to G. Chan and K. Salvatori for technical assistance, A. O'Brien for administrative support, and J. Armstrong for helpful discussions. Dr. D. A. Bernlohr kindly provided aP2 antibody.
| |
FOOTNOTES |
|---|
This work was supported by National Institutes of Health Grants DK-56891 and AG/DK-13925 (to J. L. Kirkland), DK-46200 (Adipocyte Core; to J. L. Kirkland), DK-59261 (to W. Guo), DK-54588 (to G. Waloga), and DK-45343 (to M. D. Jensen).
Address for reprint requests and other correspondence: J. L. Kirkland, Room F435, Boston University Medical Center, 88 East Newton St., Boston, MA 02118.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpregu.00653.2001
Received 5 November 2001; accepted in final form 27 December 2001.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Adams, M,
Montague CT,
Prins JB,
Holder JC,
Smith SA,
Sanders L,
Digby JE,
Sewter CP,
Lazar MA,
Chatterjee VK,
and
O'Rahilly S.
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
J Clin Invest
100:
3149-3153,
1997[ISI][Medline].
2.
Arner, P.
Regional adiposity in man.
J Endocrinol
155:
191-192,
1997[ISI][Medline].
3.
Auboeuf, D,
Bieusset J,
Fajas L,
Vallier P,
Frering V,
Riou JP,
Staels B,
Auwerx J,
Laville M,
and
Vidal H.
Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor- in humans.
Diabetes
46:
1319-1327,
1997[Abstract].
4.
Barak, Y,
Nelson MC,
Ong ES,
Jones YZ,
Ruiz-Lozano P,
Chien KR,
Koder A,
and
Evans RM.
PPAR is required for placental, cardiac, and adipose tissue development.
Mol Cell
4:
585-595,
1999[ISI][Medline].
5.
Bouchard, C,
Després JP,
and
Mauriège P.
Genetic and nongenetic determinants of regional fat distribution.
Endocr Rev
14:
72-93,
1993[ISI][Medline].
6.
Caserta, F,
Tchkonia T,
Civelek V,
Prentki M,
Brown NF,
McGarry JD,
Forse RA,
Corkey BE,
Hamilton JA,
and
Kirkland JL.
Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes.
Am J Physiol Endocrinol Metab
280:
E238-E247,
2001
7.
Chomczynski, P,
and
Sacchi N.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:
156-159,
1987[ISI][Medline].
8.
Després, JP.
The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
Obesity Res
6, Suppl1:
8S-17S,
1998[Medline].
9.
Djian, P,
Roncari DAK,
and
Hollenberg CH.
Adipocyte precursor clones vary in capacity for differentiation.
Metabolism
34:
880-883,
1985[ISI][Medline].
10.
Djian, P,
Roncari DAK,
and
Hollenberg CH.
Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture.
J Clin Invest
72:
1200-1208,
1983.
11.
Edens, NK,
Fried SK,
Kral JG,
Hirsch J,
and
Leibel RL.
In vitro lipid synthesis in human adipose tissue from three abdominal sites.
Am J Physiol Endocrinol Metab
265:
E374-E379,
1993
12.
El Jack, AK,
Hamm JK,
Pilch PF,
and
Farmer SR.
Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPAR and C/EBP.
J Biol Chem
274:
7946-7951,
1999
13.
Entenmann, G,
and
Hauner H.
Relationship between replication and differentiation in cultured human adipocyte precursor cells.
Am J Physiol Cell Physiol
270:
C1011-C1016,
1996
14.
Fried, SK,
Russell CD,
Grauso NL,
and
Brolin RE.
Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.
J Clin Invest
92:
2191-2198,
1993.
15.
Fujioka, S,
Matsuzawa Y,
Tokunaga K,
Kawamoto T,
Kobatake T,
Keno Y,
Kotani K,
Yoshida S,
and
Tarui S.
Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity.
Int J Obes
15:
853-859,
1990.
16.
Gillum, RF.
The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years.
J Chron Dis
40:
421-428,
1987[ISI][Medline].
17.
Green, H,
and
Kehinde O.
Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells.
Cell
7:
105-113,
1976[ISI][Medline].
18.
Hartman, AD.
Adipocyte fatty acid mobilization in vivo: effects of age and anatomical location.
Lipids
20:
255-261,
1985[ISI][Medline].
19.
Hauner, H,
and
Entenmann G.
Regional variation of adipose differentiation in cultured stromal-vascular cells from the abdominal and femoral adipose tissue of obese women.
Int J Obes
15:
121-126,
1991[ISI][Medline].
20.
Hauner, H,
Entenmann G,
Wabitsch M,
Gaillard D,
and
Ailhaud G.
Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium.
J Clin Invest
84:
1663-1670,
1989.
21.
Hauner, H,
Petruschke T,
Russ M,
Rohrig K,
and
Eckel J.
Effects of tumor necrosis factor-alpha (TNF-) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture.
Diabetologia
38:
764-771,
1995[ISI][Medline].
22.
Hollenberg, AN,
Susulic VS,
Madura JP,
Zhang B,
Moller DE,
Tontonoz P,
Sarraf P,
Spiegelman BM,
and
Lowell BB.
Functional antagonism between CCAAT/enhancer binding protein- and peroxisome proliferator-activated receptor- on the leptin promoter.
J Biol Chem
272:
5283-5290,
1997
23.
Hube, F,
Lietz U,
Igel M,
Jensen PB,
Tornqvist H,
Joost HG,
and
Hauner H.
Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans.
Horm Metab Res
28:
690-693,
1996[ISI][Medline].
24.
Kachigan, SK.
Statistical Analysis. New York: Radius, 1986.
25.
Kannel, WB,
Cupples LA,
Ramaswami R,
Stokes J,
Kreger BE,
and
Higgins M.
Regional obesity and risk of cardiovascular disease: the Framingham study.
J Clin Epidemiol
44:
183-190,
1991[ISI][Medline].
26.
Karagiannides, I,
Tchkonia T,
Dobson DE,
Steppan CM,
Cummins P,
Chan G,
Salvatori K,
Hadzopoulou-Cladaras M,
and
Kirkland JL.
Altered expression of C/EBP family members results in decreased adipogenesis with aging.
Am J Physiol Regulatory Integrative Comp Physiol
280:
R1772-R1780,
2001
27.
Kelly, I,
Han T,
Walsh K,
and
Lean M.
Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.
Diabetes Care
22:
288-293,
1999
28.
Keppel, G.
Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ: Prentice-Hall, 1973.
29.
Kirkland, JL,
Cummins P,
Steppan C,
Dobson DE,
and
Cladaras MH.
Decreasing preadipocyte differentiation capacity with aging is associated with blunted expression of the transcription factor, CCAAT enhancer binding protein .
Obesity Res
5, Suppl1:
22S,
1997.
30.
Kirkland, JL,
and
Dax EM.
Adipose hormone responsiveness and aging in the rat.
J Am Geriatr Soc
32:
219-228,
1984[ISI][Medline].
31.
Kirkland, JL,
Hollenberg CH,
Gillon W,
and
Kindler S.
Effect of hypophysectomy on rat preadipocyte replication and differentiation.
Endocrinology
131:
2769-2773,
1992[Abstract].
32.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Age, anatomic site, and the replication and differentiation of adipocyte precursors.
Am J Physiol Cell Physiol
258:
C206-C210,
1990
33.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes.
Int J Obes
20:
S102-S107,
1996[ISI].
34.
Kirkland, JL,
Piñeyro MA,
Lu Z,
and
Gregerman RI.
Hormone sensitive adenylyl cyclase in preadipocytes cultured from adipose tissue: comparison with 3T3-L1 cells and adipocytes.
J Cell Physiol
133:
449-460,
1987[ISI][Medline].
35.
Kissebah, A,
Vydelingum N,
Murray R,
Evans DJ,
Hartz AJ,
Kalkhoff RK,
and
Adams PW.
Relation of body fat distribution to metabolic complications of obesity.
J Clin Endocrinol Metab
54:
254-260,
1982[Abstract].
36.
Kissebah, AH,
and
Hennes MMI
Central obesity and free fatty acid metabolism.
Prostaglandins Leukot Essent Fatty Acids
52:
209-211,
1995[ISI][Medline].
37.
Kissebah, AH,
and
Krakower GR.
Regional adiposity and morbidity.
Physiol Rev
74:
761-811,
1994
38.
Kleinbaum, D,
Kupper L,
and
Muller K.
Applied Regression Analysis and Other Multivariate Methods. Belmont, CA: Duxbury, 1998.
39.
Kozak, LP,
and
Jensen JT.
Genetic and developmental control of multiple forms of l-glycerol 3-phosphate dehydrogenase.
J Biol Chem
249:
7775-7781,
1974
40.
Krotkiewski, M,
Björntorp P,
Sjöström L,
and
Smith U.
Impact of obesity on men and women: importance of regional adipose tissue distribution.
J Clin Invest
72:
1150-1162,
1983.
41.
Kypreos, K,
Teusink B,
Van Dijk K,
Havekes L,
and
Zannis V.
Analysis of the structure and function relationship of the human apolipoprotein E in vivo, using adenovirus-mediated gene transfer.
FASEB J
15:
1598-1600,
2001
42.
Lacasa, D,
Garcia E,
Agli B,
and
Giudicelli Y.
Control of rat preadipocyte adipose conversion by ovarian status: regional specificity and possible involvement of the mitogen-activated protein kinase-dependent and c-fos signaling pathways.
Endocrinology
138:
2729-2734,
1997
43.
Laemmli, UK.
Cleavage of structural proteins during the assembly of the head of the bacteriophage T4.
Nature
227:
680-685,
1970[Medline].
44.
Lapidus, L,
Bengtsson C,
Larsson B,
Pennert K,
Rybo E,
and
Sjostrom L.
Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenberg, Sweden.
Br Med J
289:
1257-1261,
1984.
45.
Majumdar, S.
Protein kinase C isotypes and signaling in neutrophils.
J Biol Chem
266:
9285-9294,
1991
46.
Miller, WH,
Faust IM,
and
Hirsch J.
Demonstration of de novo production of adipocytes in adult rats by biochemical and radioautographic techniques.
J Lipid Res
25:
336-347,
1984[Abstract].
47.
Montague, CT,
Prins JB,
Sanders L,
Digby JE,
and
O'Rahilly S.
Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.
Diabetes
46:
342-347,
1997[Abstract].
48.
Mori, Y,
Murakawa Y,
Okada K,
Horikoshi H,
Yokoyama J,
Tajima N,
and
Ikeda Y.
Effect of troglitazone on body fat distribution in type 2 diabetic patients.
Diabetes Care
22:
288-293,
1999.
49.
Morin, CL,
Pagliassotti MJ,
Windmiller D,
and
Eckel RH.
Adipose tissue-derived tumor necrosis factor- activity is elevated in older rats.
J Gerontol
52A:
B190-B195,
1997[ISI].
50.
Niessler, CU,
Siddle K,
and
Prins JB.
Human preadipocytes display a depot-specific susceptibility to apoptosis.
Diabetes
47:
1365-1368,
1998[Abstract].
51.
Peiris, AN,
Hennes MI,
Evans DJ,
Wilson CR,
Lee MB,
and
Kissebah AH.
Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women.
Acta Med Scand
723, Suppl:
179-188,
1988.
52.
Perrin, S.
Transcriptional control of the mouse glycerol-3-phosphate dehydrogenase gene.
In: Biochemistry. Boston, MA: Boston Univ. Press, 1995.
53.
Prins, JB,
and
O'Rahilly S.
Regulation of adipose cell number in man.
Clin Sci
92:
3-11,
1997[Medline].
54.
Roncari, DAK,
Lau DCW,
and
Kindler S.
Exaggerated replication in culture of adipocyte precursors from massively obese persons.
Metabolism
30:
425-427,
1981[ISI][Medline].
55.
Rosen, ED,
Sarraf P,
Troy AE,
Bradwin G,
Moore K,
Milstone DS,
Spiegelman BM,
and
Mortensen RM.
PPAR is required for the differentiation of adipose tissue in vivo and in vitro.
Mol Cell
4:
611-617,
1999[ISI][Medline].
56.
Salter, AM,
Fong BS,
Jimenez J,
Rotstein L,
and
Angel A.
Regional variation in high-density lipoprotein binding to human adipocyte plasma membranes of massively obese subjects.
Eur J Clin Invest
17:
16-22,
1987[ISI][Medline].
57.
Sanes, JR,
Rubenstein JLR,
and
Nicolas JF.
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
EMBO J
5:
3133-3142,
1986[ISI][Medline].
58.
Tchkonia, T,
Karagiannides I,
Forse RA,
and
Kirkland JL.
Different fat depots are distinct mini-organs.
Curr Opin Endocrinol Diabetes
8:
227-234,
2001.
59.
Teichert-Kuliszewska, k,
Hamilton BS,
Deitel M,
and
Roncari DAK
Augmented production of heparin-binding mitogenic proteins by preadipocytes from massively obese persons.
J Clin Invest
90:
1226-1231,
1992.
60.
Van de Ventner, M,
Litthauer D,
and
Oelofsen W.
Catecholamine stimulated lipolysis in differentiated human preadipocytes in a serum-free, defined medium.
J Cell Biochem
54:
1-10,
1994[ISI][Medline].
61.
Wang, H,
Kirkland JL,
and
Hollenberg CH.
Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth.
J Clin Invest
83:
1741-1746,
1989.
62.
Wigler, M,
Pellicer A,
Silverstein S,
and
Axel R.
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.
Cell
14:
725-731,
1978[ISI][Medline].
63.
Wu, Z,
Rosen ED,
Brun R,
Hauser S,
Adelmant G,
Troy AE,
McKeon C,
Darlington GJ,
and
Spiegelman BM.
Cross-regulation of C/EBP and PPAR controls the transcriptional pathway of adipogenesis and insulin sensitivity.
Mol Cell
3:
151-158,
1999[ISI][Medline].
64.
Zapata, JM,
Takahashi R,
Salvesen GS,
and
Reed JC.
Granzyme release and caspase activation in activated human T-lymphocytes.
J Biol Chem
273:
6916-6920,
1998
65.
Zilberfarb, V,
Siquier K,
Strosberg AD,
and
Issad T.
Effect of dexamethasone on adipocyte differentiation markers and tumour necrosis factor- expression in human PAZ6 cells.
Diabetologia
44:
377-386,
2001[ISI][Medline].
This article has been cited by other articles:
|
|
 |
|
  J. T. M. Tan, S. V. McLennan, W. W. Song, L. W.-Y. Lo, J. G. Bonner, P. F. Williams, and S. M. Twigg Connective tissue growth factor inhibits adipocyte differentiation Am J Physiol Cell Physiol, September 1, 2008; 295(3): C740 - C751. [Abstract] [Full Text] [PDF]
|
|
|
|
), mesenteric
(
), and omental (
) preadipocytes
from 3 different patients were exposed to differentiation-inducing
medium on day 0 (n = 20-376 clones per
fat depot per patient). The mean percentages (±1 SE) of colonies that
contained at least 1 differentiated cell (doubly refractile inclusions
visible by low-power phase-contrast microscopy) after 15, 30, 45, and
60 days are shown.
